US Patent 9834604 Inhibitors of T-cell activation
Patent 9834604 was granted and assigned to Genzyme on December, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+149 characters)
Article
Patent abstract
The present invention provides a bispecific biologic comprising a ligand specific for CTLA-4 and a ligand specific for a pMHC complex.
Edits on 18 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Canwen Jiang0
Jozsef Karman0
Ronnie Wei0
Seng Cheng0
Yunxiang Zhu0
Edits on 31 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09834604 Inhibitors of T-cell activation US Patent 9834604 Inhibitors of T-cell activation
Infobox
Patent Number
098346040
Patent Number
98346040
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
098346040
Date of Patent
December 5, 2017
0Patent Application Number
141284610
Date Filed
June 29, 2012
0Patent Primary Examiner
Edits on 16 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09834604 Inhibitors of T-cell activation
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09834604
Date of patent
December 5, 2017
Patent application number
14128461
Date Filed
June 29, 2012
Patent primary examiner
Find more entities like US Patent 9834604 Inhibitors of T-cell activation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
